XML 29 R22.htm IDEA: XBRL DOCUMENT v3.26.3
Stockholders' Equity and Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Summary of Total Stock-based Compensation Expense

The table below summarizes the total stock-based compensation expense included in the Company’s statements of operations and comprehensive loss for the periods presented (in thousands):

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Research and development

$

3,164

 

 

$

2,434

 

 

$

9,913

 

 

$

8,245

 

General and administrative

 

3,026

 

 

 

3,197

 

 

 

10,266

 

 

 

10,514

 

Total stock-based compensation expense

$

6,190

 

 

$

5,631

 

 

$

20,179

 

 

$

18,759

 

Summary of Option Activity

The following table summarizes the stock option activity for the nine months ended September 30, 2026:

 

 

 

Options

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Term
(in years)

 

 

Aggregate
Intrinsic
Value
(in thousands)

 

Outstanding at December 31, 2025

 

 

13,902,239

 

 

$

6.49

 

 

 

 

 

 

 

Granted

 

 

3,896,158

 

 

$

8.60

 

 

 

 

 

 

 

Exercised

 

 

(473,113

)

 

$

4.67

 

 

 

 

 

 

 

Forfeited and cancelled

 

 

(186,928

)

 

$

8.65

 

 

 

 

 

 

 

Outstanding at September 30, 2026

 

 

17,138,356

 

 

$

6.99

 

 

 

7.0

 

 

$

112,494

 

Exercisable at September 30, 2026

 

 

10,494,572

 

 

$

5.94

 

 

 

5.9

 

 

$

80,484

 

Summary of Fair Value of Stock Options Estimated Using Black-Scholes Merton Option Pricing Model Assumptions

The fair value of stock option awards to employees, executives, directors, and other service providers was estimated at the date of grant using the Black-Scholes-Merton option pricing model with the following assumptions:

 

 

 

Nine Months Ended
September 30,

 

 

2026

 

2025

Risk-free interest rate

 

3.73% - 4.61%

 

3.87% - 4.43%

Expected volatility

 

84.89% - 87.57%

 

83.11% - 85.76%

Expected term (in years)

 

5.50 - 6.08

 

5.50 - 6.08

Expected dividend yield

 

0%

 

0%

Summary of Restricted Stock Unit Activity

The following table summarizes the restricted stock unit activity for the nine months ended September 30, 2026:

 

 

Number of Shares

 

 

Weighted-
Average
Grant-Date
Fair Value

 

Outstanding at December 31, 2025

 

 

582,533

 

 

$

8.96

 

Granted

 

 

614,949

 

 

$

8.61

 

Vested

 

 

(59,301

)

 

$

9.67

 

Forfeited

 

 

(25,929

)

 

$

8.79

 

Outstanding at September 30, 2026

 

 

1,112,252

 

 

$

8.73

 

Summary of Outstanding Shares of Potential Dilutive Securities Excluded from Computation of Diluted Net Loss per Share

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Options to purchase common stock

 

17,138,356

 

 

 

14,130,668

 

 

 

17,138,356

 

 

 

14,130,668

 

Non-vested restricted stock units

 

1,112,252

 

 

 

945,945

 

 

 

1,112,252

 

 

 

945,945

 

Total

 

18,250,608

 

 

 

15,076,613

 

 

 

18,250,608

 

 

 

15,076,613